HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PKC delta and epsilon in drug targeting and therapeutics.

Abstract
Protein kinase C (PKC) belongs to the serine and threonine kinase family. At least ten PKC isoforms have been identified and subdivided into three groups: classical (alpha, beta I, beta II and gamma), novel (delta, epsilon, theta and eta), and atypical (zeta and iota/lambda). Two calcium-insensitive isoforms of novel PKC, PKC delta and epsilon, have received particular attention as promising targets for new drugs. PKCs play a multifaceted role in cellular responses in a range of tissues. Professor Mochly-Rosen's group and KAI Pharmaceuticals Inc. have developed drugs targeted against PKC delta (KAI-9803) and epsilon (KAI-1678). These drugs ameliorate pathological conditions in acute myocardial infarction and reduce pain via specific modulation of membrane-translocation of PKC delta or epsilon. Another research group has recently used the KinAce() approach to produce PKC epsilon-abrogating peptides (KCe-12 and KCe-16) that are based on the catalytic domain of PKC. These peptides specifically inhibit PKC epsilon and ameliorate pathological conditions in a rodent insulin resistance model. This review describes the development of these therapeutic drugs targeting PKC delta and epsilon by two independent groups in the light of recent patents.
AuthorsTomo Yonezawa, Riho Kurata, Minoru Kimura, Hidetoshi Inoko
JournalRecent patents on DNA & gene sequences (Recent Pat DNA Gene Seq) Vol. 3 Issue 2 Pg. 96-101 ( 2009) ISSN: 2212-3431 [Electronic] United Arab Emirates
PMID19519579 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Enzyme Inhibitors
  • KAI 9803
  • KAI-1678
  • Peptides
  • Protein Kinase C-delta
  • Protein Kinase C-epsilon
Topics
  • Animals
  • Enzyme Inhibitors (therapeutic use)
  • Gene Targeting
  • Humans
  • Patents as Topic
  • Peptides (therapeutic use)
  • Protein Kinase C-delta (antagonists & inhibitors, genetics, metabolism)
  • Protein Kinase C-epsilon (antagonists & inhibitors, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: